Pure Monograph vs Veeva Vault RIM
Veeva Vault RIM is the system of record most regulated pharma sponsors use for registrations, submissions, publishing, and archive. Pure Monograph is an AI authoring and intelligence layer that sits upstream of Vault. Almost every mid-market and enterprise sponsor who evaluates both ends up running them side by side.
Short answer. Vault RIM is your regulated content system — versioning, workflow, eCTD publishing, archive. Pure Monograph is your drafting and intelligence accelerator — first-pass CTD Module 3 content, tech transfer packages, BMRs, stability content, competitive monitoring. They are not competitive products; they sit at different points in the document lifecycle.
At a glance
| Dimension | Pure Monograph | Veeva Vault RIM |
|---|---|---|
| Primary deliverable | First-draft CTD sections, tech transfer packages, BMRs, intelligence briefs | Registrations, Submissions, Submissions Publishing, Submissions Archive content lifecycle |
| Category | AI authoring & intelligence | Regulated content management / RIM suite |
| Regulatory output | Drafts aligned to ICH M4, Q-series, 21 CFR, USP — exported as Word / PDF / Excel | Validated eCTD publishing, lifecycle control, agency submission |
| AI positioning | Core product from day one | AI Agents for Regulatory scheduled August 2026 on Vault Direct Data |
| Pricing | $0-$1,499 per month self-serve; $7,500-$80,000 USD request-based packages | Enterprise contracts, multi-module suite licensing |
| Engagement model | Self-serve subscription plus optional concierge package | Enterprise sales, implementation partner engagement |
| Ownership | Burrard Pharmaceutical Enterprises Ltd., Vancouver BC | Veeva Systems Inc. (NYSE: VEEV) |
Where the seam sits
A Module 3 section lives four lives: (1) first draft, (2) scientific review, (3) regulatory review and versioning, (4) eCTD publish. Pure Monograph owns the first life and feeds an exportable Word / PDF into the second. Vault RIM picks up the artifact at scientific or regulatory review and owns lives 2 through 4. Nothing about the two products forces an either/or choice.
When Veeva alone is not enough
Teams that rely on Vault RIM still need a drafting pipeline. Traditionally this means consulting hours, junior regulatory writers, or in-house SMEs. Pure Monograph compresses the first-draft cycle from weeks to hours with Q&A-grounded content tied to current ICH and 21 CFR references. Vault's own AI agents (August 2026 roadmap) will add drafting capability inside Vault — complementary but targeted at content already in the Vault environment.
Frequently asked questions
Does Pure Monograph replace Veeva Vault RIM?
No. Vault RIM is the system of record for registrations, submissions, publishing, and archive. Pure Monograph is an AI authoring and intelligence layer that produces the drafts and evidence tables that flow into Vault or another validated eCTD system.
What does the Veeva Vault RIM suite include?
Registrations, Submissions, Submissions Publishing, and Submissions Archive. Veeva has publicly disclosed AI Agents for Regulatory on the Vault Direct Data platform, scheduled for August 2026.
Can I use both?
Yes. Draft in Pure Monograph, review and version in Vault RIM Submissions, publish and archive through the Vault pipeline. Most mid-market and enterprise sponsors who evaluate both settle on exactly this workflow.
Why pick Pure Monograph if I already have Vault?
Vault manages content lifecycle but does not draft it. Pure Monograph accelerates the upstream authoring work before artifacts enter the Vault lifecycle.